Newron Pharmaceuticals SpA (NWRN) — Cash Flow Reinvestment Rate
Newron Pharmaceuticals SpA (NWRN) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting CHF31.00K (capex CHF31.00K ) from operating cash flow of CHF33.35 Million. See free cash flow generation of Newron Pharmaceuticals SpA to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Newron Pharmaceuticals SpA Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Newron Pharmaceuticals SpA across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Newron Pharmaceuticals SpA.
Annual Cash Flow Reinvestment Rate for Newron Pharmaceuticals SpA (2012–2025)
Year-by-year capital reinvestment analysis for Newron Pharmaceuticals SpA. See Newron Pharmaceuticals SpA (NWRN) financial flexibility to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CHF) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | CHF13.66 Million | CHF32.56 Million | CHF47.30K | ▲ +22121.3% |
| 2012 | 0.00x | CHF11.00K | CHF5.83 Million | CHF11.00K | — |